Oral pharmacokinetics of cyclosporin in patients with primary biliary Cirrhosis and patients with skin diseases
โ Scribed by R. BEUKERS; S. DE RAVE; J. W. O. VAN DEN BERG; S. W. SCHALM
- Book ID
- 108603107
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 596 KB
- Volume
- 6
- Category
- Article
- ISSN
- 0269-2813
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Symptomatology and objective findings of Sjogren's syndrome were evaluated in 38 consecutive patients with primary biliary cirrhosis. Symptoms of Sjogren's syndrome were present in 18 (47.4%) patients, but were severe enough to warrant therapy in only four (10.6%). Nineteen patients consented to eva
An impaired sulfoxidation pathway has been implicated in the pathogenesis of chlorpromazineinduced hepatotoxicity. Since some patients with chronic chlorpromazine-induced cholestasis may have features of primary biliary cirrhosis, we studied the ability to sulfoxidate the amino acid analogue 5'-carb
The impact of primary biliary cirrhosis (PBC) on health-related quality of life (HRQOL) is poorly documented. We assessed quality of life in a group of 276 unselected patients with PBC using the Nottingham Health Profile (NHP). This is a generic scale that assesses six major areas commonly associate